The first total synthesis of the undecylprodigiosin was published in 1966, confirming the chemical structure. As with the biosynthesis, the key intermediate was MBC.[2][3]
Uses
As with other prodiginines, the compound has been investigated for its pharmaceutical potential as anticancer, immunosuppressant, or antimalarial agent.[1][4]
^Wasserman, H. H.; Rodgers, G. C.; Keith, D. D. (1966). "The structure and synthesis of undecylprodigiosin. A prodigiosin analogue from Streptomyces". Chemical Communications (22): 825–826. doi:10.1039/C19660000825.
^Stankovic, Nada; Senerovic, Lidija; Ilic-Tomic, Tatjana; Vasiljevic, Branka; Nikodinovic-Runic, Jasmina (2014). "Properties and applications of undecylprodigiosin and other bacterial prodigiosins". Applied Microbiology and Biotechnology. 98 (9): 3841–3858. doi:10.1007/s00253-014-5590-1. PMID24562326. S2CID16834175.